Delivery Order SPE2DR25D2205-SPE2DR26F1S53
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Nitazoxanide 500 mg tablets in quantities of six units. This firm fixed-price delivery order, valued at $3,512.48, represents a non-competitive set-aside and is scheduled for completion by November 6, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Nitazoxanide 500 mg tablets with a ceiling value of $25,276.20. This is a firm fixed-price, non-set-aside delivery order issued on January 2, 2026, with an ultimate completion date of January 5, 2026. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs across military and veteran healthcare systems. This delivery...
- The Defense Logistics Agency awarded a $3,477.04 delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Nitazoxanide 500 mg tablets in quantities of six. The contract is firm fixed price with no set-aside designation and is scheduled for completion by August 14, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and is registered in the System for Award...
- The Defense Logistics Agency awarded a $4,212.70 firm fixed price delivery order to AmerisourceBergen Drug Corp on December 10, 2025, for Nitazoxanide 500 mg tablets in quantities of six. This competitively awarded, non-set-aside contract is scheduled for ultimate completion on December 11, 2025, with performance at the vendor's Conshohocken, Pennsylvania location. The order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order valued at $12,378.20 to AmerisourceBergen Drug Corp for the supply of Nitazoxanide 500 mg tablets (quantity of six units) on December 9, 2025, with completion scheduled for December 10, 2025. The award is structured as a firm fixed price delivery order with no set-aside designation, indicating competitive selection. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the...
- The Defense Logistics Agency awarded a $27,816.49 delivery order to AmerisourceBergen Drug Corp for Nitazoxanide 500mg tablets (6 count) with a completion date of January 12, 2026. This non-set-aside, competitively awarded contract represents a firm fixed-price delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 global pharmaceutical support vehicle valued through December 2026. The place of performance is...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $24,743.79 firm fixed-price delivery order is for the supply of 4,567,202,446 units of the drug Nitazoxanide 500 mg tablets. The contract has an ultimate completion date of February 10, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
- This federal contract award, valued at $11,207.18, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567269176 NITAZOXANIDE 500 MG TABLET 6S, a pharmaceutical product, with a completion date of February 14, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type, and does not have a set-aside designation, indicating open competition....
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The $3,699.22 firm-fixed-price contract is for the supply of 4565295255 - Nitazoxanide 500 mg tablets. The contract has an ultimate completion date of July 31, 2024 and was awarded on July 30, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 between DLA Troop Support Medical and AmerisourceBergen, which provides a...
- The Defense Logistics Agency awarded a delivery order valued at $3,212.33 to AmerisourceBergen Drug Corp for Nitazoxanide 500 mg tablets in quantities of six, with an ultimate completion date of August 15, 2025. This firm fixed-price, non-set-aside contract was awarded on August 14, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Nitazoxanide is an antiprotozoal and antiviral medication commonly used to treat parasitic and infectious...
- SPE2DR25D2205Indefinite Delivery Contract
- SPE2DR25D2205-SPE2DR26F1S53Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on December 31, 2025, for the supply of Nitazoxanide 500 mg tablets in quantities of six units. This is a firm fixed price contract with a ceiling value of $26.5K and an ultimate completion date of January 2, 2026. The contract was awarded without a set-aside designation on a competitive basis and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for the military healthcare system. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's portfolio includes a wide range of pharmaceutical products and medical supplies across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, vaccines, and medical devices. The parent IDC with DLA Troop Support Medical enables AmerisourceBergen to supply pharmaceutical products globally to support military healthcare programs and other government healthcare systems, including the Defense Health Agency and U.S. Coast Guard, demonstrating the company's significant role in the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $26.5k | 12/30/25 |